Literature DB >> 27075964

Transplantation of Human Urine-Derived Stem Cells Transfected with Pigment Epithelium-Derived Factor to Protect Erectile Function in a Rat Model of Cavernous Nerve Injury.

Qiyun Yang1, Xin Chen1, Tao Zheng1, Dayu Han1, Heng Zhang1, Yanan Shi2, Jun Bian3, Xiangzhou Sun1, Kai Xia1, Xiaoyan Liang2, Guihua Liu2, Yuanyuan Zhang4, Chunhua Deng1.   

Abstract

The aim of this study was to investigate whether intracavernous injection of urine-derived stem cells (USCs) or USCs genetically modified with pigment epithelium-derived factor (PEDF) could protect the erectile function and cavernous structure in a bilateral cavernous nerve injury-induced erectile dysfunction (CNIED) rat model. USCs were cultured from the urine of six healthy male donors. Seventy-five rats were randomly divided into five groups ( n = 15 per group): sham, bilateral cavernous nerve (CN) crush injury (BCNI), USC, USCGFP+, and USCGFP/PEDF+ groups. The sham group received only laparotomy without CN crush injury and intracavernous injection with phosphate-buffered saline (PBS). All of the other groups were subjected to BCNI and intracavernous injection with PBS, USCs, USCsGFP+, or USCsGFP/PEDF+, respectively. The total intracavernous pressure (ICP) and the ratio of ICP to mean arterial pressure (ICP/MAP) were recorded. The penile dorsal nerves, the endothelium, and the smooth muscle were assessed within the penile tissue. The USC and USCGFP/PEDF+ groups displayed more significantly enhanced ICP and ICP/MAP ratio ( p < 0.05) 28 days after cell transplantation. Immunohistochemistry (IHC) and Western blot analysis demonstrated that the protection of erectile function and the cavernous structure by USCsGFP/PEDF+ was associated with an increased number of nNOS-positive fibers within the penile dorsal nerves, improved expression of endothelial markers (CD31 and eNOS) and a smooth muscle marker (smoothelin), an enhanced smooth muscle to collagen ratio, decreased expression of transforming growth factor-β1 (TGF-β1), and decreased cell apoptosis in the cavernous tissue. The paracrine effect of USCs and USCsGFP/PEDF+ prevented the destruction of erectile function and the cavernous structure in the CNIED rat model by nerve protection, thereby improving endothelial cell function, increasing the smooth muscle content, and decreasing fibrosis and cell apoptosis in the cavernous tissue.

Entities:  

Keywords:  Cavernous never injury; Erectile dysfunction (ED); Pigment epithelium-derived factor (PEDF); Urine-derived stem cells (USCs)

Mesh:

Substances:

Year:  2016        PMID: 27075964     DOI: 10.3727/096368916X691448

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  13 in total

1.  Effects of the donor age on proliferation, senescence and osteogenic capacity of human urine-derived stem cells.

Authors:  Peng Gao; Peilin Han; Dapeng Jiang; Shulong Yang; Qingbo Cui; Zhaozhu Li
Journal:  Cytotechnology       Date:  2017-04-13       Impact factor: 2.058

2.  Urine-derived stem cells accelerate the recovery of injured mouse hepatic tissue.

Authors:  Chaoqun Hu; Yun He; Shuyu Fang; Na Tian; Mengjia Gong; Xiaohui Xu; Li Zhao; Yi Wang; Tongchuan He; Yuanyuan Zhang; Yang Bi
Journal:  Am J Transl Res       Date:  2020-09-15       Impact factor: 4.060

3.  Impaired Regeneration Potential in Urinary Stem Cells Diagnosed from the Patients with Diabetic Nephropathy.

Authors:  Geng Xiong; Weiqing Tang; Deying Zhang; David He; Guanghui Wei; Antony Atala; Xing-Jie Liang; Anthony J Bleyer; Michael E Bleyer; Jie Yu; Joseph A Aloi; Jian-Xing Ma; Cristina M Furdui; Yuanyuan Zhang
Journal:  Theranostics       Date:  2019-05-31       Impact factor: 11.556

Review 4.  Urine-Derived Stem Cells: Applications in Regenerative and Predictive Medicine.

Authors:  Guida Bento; Aygul K Shafigullina; Albert A Rizvanov; Vilma A Sardão; Maria Paula Macedo; Paulo J Oliveira
Journal:  Cells       Date:  2020-02-28       Impact factor: 6.600

5.  Guilingji Protects Against Spermatogenesis Dysfunction From Oxidative Stress via Regulation of MAPK and Apoptotic Signaling Pathways in Immp2l Mutant Mice.

Authors:  Zhenqing Wang; Yun Xie; Haicheng Chen; Jiahui Yao; Linyan Lv; Yanqing Li; Chunhua Deng; Min Zhang; Xiangzhou Sun; Guihua Liu
Journal:  Front Pharmacol       Date:  2022-01-13       Impact factor: 5.810

Review 6.  Urine-derived cells for human cell therapy.

Authors:  Nimshitha Pavathuparambil Abdul Manaph; Mohammed Al-Hawwas; Larisa Bobrovskaya; Patrick T Coates; Xin-Fu Zhou
Journal:  Stem Cell Res Ther       Date:  2018-07-11       Impact factor: 6.832

7.  Transplantation of Human Urine-Derived Stem Cells Ameliorates Erectile Function and Cavernosal Endothelial Function by Promoting Autophagy of Corpus Cavernosal Endothelial Cells in Diabetic Erectile Dysfunction Rats.

Authors:  Chi Zhang; Daosheng Luo; Tingting Li; Qiyun Yang; Yun Xie; Haicheng Chen; Linyan Lv; Jiahui Yao; Cuncan Deng; Xiaoyan Liang; Rongpei Wu; Xiangzhou Sun; Yuanyuan Zhang; Chunhua Deng; Guihua Liu
Journal:  Stem Cells Int       Date:  2019-09-09       Impact factor: 5.443

8.  FOXO4-DRI alleviates age-related testosterone secretion insufficiency by targeting senescent Leydig cells in aged mice.

Authors:  Chi Zhang; Yun Xie; Haicheng Chen; Linyan Lv; Jiahui Yao; Min Zhang; Kai Xia; Xin Feng; Yanqing Li; Xiaoyan Liang; Xiangzhou Sun; Chunhua Deng; Guihua Liu
Journal:  Aging (Albany NY)       Date:  2020-01-20       Impact factor: 5.682

9.  Engineered Stem Cells Improve Neurogenic Bladder by Overexpressing SDF-1 in a Pelvic Nerve Injury Rat Model.

Authors:  Guan Qun Zhu; Seung Hwan Jeon; Kyu Won Lee; Hyuk Jin Cho; U-Syn Ha; Sung-Hoo Hong; Ji Youl Lee; Eun Bi Kwon; Hyo-Jin Kim; Soon Min Lee; Hey-Yon Kim; Sea Woong Kim; Woong Jin Bae
Journal:  Cell Transplant       Date:  2020 Jan-Dec       Impact factor: 4.064

Review 10.  Stem cell-based therapies for fertility preservation in males: Current status and future prospects.

Authors:  Han-Chao Liu; Yun Xie; Chun-Hua Deng; Gui-Hua Liu
Journal:  World J Stem Cells       Date:  2020-10-26       Impact factor: 5.326

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.